Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MATCH: Varenicline vs Bupropion for Smoking Cessation
NCT02146911Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- May 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of varenicline and bupropion in Tobacco Use Disorder (TUD) and nicotine dependence, sponsored by Center for Addiction and Mental Health. Primary endpoint: Change in smoking status over time at 52 weeks. Started May 2014; status: completed.
02
Drugs
vareniclinebupropion
03
Conditions
Tobacco Use Disorder (TUD)nicotine dependence
Beyond the preview
Go deeper on NCT02146911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02146911.